Table 1 29 medical indices in input neurons
Neurons | Â | Inputs |
|---|---|---|
\(x_{01}\) | Baseline characteristics | Age |
\(x_{02}\) | Â | Region (city/rural) |
\(x_{03}\) | History | History of live birth* (frequency) (city/rural) |
\(x_{04}\) | Â | History of spontaneous abortion* (frequency) |
\(x_{05}\) | Â | History of therapeutic abortion* (frequency) |
\(x_{06}\) | Â | History of artificial abortion* (frequency) |
\(x_{07}\) | Â | Other adverse reproductive history irrelevant to SLE (frequency) |
\(x_{08}\) | Â | History of caesarean (frequency) |
\(x_{09}\) | Â | Other chronic disease: Diabetes/Hypertension (Y/N) |
\(x_{10}\) | Â | History of SLE (years) |
\(x_{11}\) | Â | Pre-gestational SLE status Remission stage (Y/N) |
\(x_{12}\) | Â | Pre-gestational SLE status Active stage (Y/N) |
\(x_{13}\) | Â | Pre-gestational SLE status Initial onset (Y/N) |
\(x_{14}\) | Clinical manifestation | Nephritis (Y/N) |
\(x_{15}\) | Â | Cutaneous lesion (Y/N) |
\(x_{16}\) | Â | Hematological disorder (Y/N) |
\(x_{17}\) | Â | Arthritis (Y/N) |
\(x_{18}\) | Â | Serositis (Y/N) |
\(x_{19}\) | Laboratory data | Anti-Ro/SSA (Positive/Negative) |
\(x_{20}\) | Â | Anti-La / SSB (Positive/Negative) |
\(x_{21}\) | Â | Anti-dsDNA (Positive/Negative) |
\(x_{22}\) | Â | Anti-Sm (Positive/Negative) |
\(x_{23}\) | Â | APL (Positive/Negative) |
\(x_{24}\) | Â | C3 hypocomplementania-C3 (g/L) |
\(x_{25}\) | Â | C4 hypocomplementania-C4 (g/L) |
\(x_{26}\) | Â | 24-hour-urinary protein level (g/L) |
\(x_{27}\) | Â | ADP(\(\%\)) |
\(x_{28}\) | Treatments | Glucocorticoid (Y/N) |
\(x_{29}\) | Â | Asprin (Y/N) |